This inventor holds 2 USPTO granted patents. Top assignee: Ss Pharmaceutical Co., Ltd.. Active years: 1994-1995.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1994-1995
Title: Satoru Enomoto: Innovator in Pharmaceutical Gel Preparations
Introduction
Satoru Enomoto is a notable inventor based in Narita, Japan. He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of anti-inflammatory and analgesic gel preparations. With a total of 2 patents, Enomoto's work has garnered attention for its innovative approach to enhancing drug delivery.
Latest Patents
Enomoto's latest patents include an anti-inflammatory and analgesic gel preparation. This formulation comprises diclofenac or its salts, an ester of dibasic acid, a lower alcohol, and a nonionic polymer or a mixture of nonionic polymers. The specific polymers used include hydroxypropyl cellulose and hydroxyethyl cellulose, which are crucial for achieving the desired viscosity and yield value. The gel preparation is designed to enhance the percutaneous absorption of diclofenac, providing superior medical effects and user experience.
Career Highlights
Throughout his career, Satoru Enomoto has focused on developing innovative pharmaceutical solutions. His work at Ss Pharmaceutical Co., Ltd. has positioned him as a key player in the industry. Enomoto's dedication to improving drug formulations has led to advancements that benefit both healthcare providers and patients.
Collaborations
Enomoto has collaborated with notable colleagues such as Shuichi Kasai and Yasuo Ikeda. These partnerships have contributed to the successful development of his patented formulations and have fostered a collaborative environment for innovation.
Conclusion
Satoru Enomoto's contributions to pharmaceutical gel preparations highlight his role as an influential inventor in the field. His innovative formulations continue to pave the way for advancements in drug delivery systems.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile